Article
[Biomarker analysis from a pathologist's view. Founding the rationale for personalised treatment of lung cancer].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz - 1 Nov 2013
Buettner R, Heydt C
Abstract excerpt
The advent of genomic medicine and sequencing analysis of entire cancer genomes has rapidly improved our understanding of cancer genomics and has defined pathogenetic lesions initiating and driving cancer phenotypes in a causative manner. Moreover rapid development of small molecule inhibitors and highly selective biologicals provided effective tools to intervene with oncogenic signalling resulting from such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
